Arkolith/Insider Trading/CASI/Form 4

Huang James

DirectorCASI Pharmaceuticals, Inc. (CASI) · full profile →Form 4 · filed Aug 26, 2022
Net Buying
Open-Market Buys
$167K
Open-Market Sells
$0
Net Open-Market Flow
$167K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 26, 2022Buy(P)40K$3.75$148K279K
Aug 24, 2022Buy(P)5K$3.75$19K239K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-22-029897) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML